Takeshi Umibe
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies 3
- Eosinophilic Disorders and Syndromes 2
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 3
-
- Vasculitis and related conditions 4
-
- Renal Diseases and Glomerulopathies 3
-
- Asthma and respiratory diseases 3
-
- Vascular Malformations and Hemangiomas 2
-
- Viral Infections and Immunology Research 2
- Co-authors
- Hiroshi NakajimaRyutaro MatsumuraKei IkedaShunsuke FurutaTakao SugiyamaItsuo IwamotoShin‐ichiro KagamiMasaki Hiraguri
- Cited by
- RheumatologyImmunologyGenetics
In The Last Decade
Takeshi Umibe
16 papers receiving 253 citations
Peers
Comparison fields: 5 of 40
- Rheumatology 168
- Immunology 66
- Genetics 32
- Pulmonary and Respiratory Medicine 89
- Nephrology 17
Countries citing papers authored by Takeshi Umibe
This map shows the geographic impact of Takeshi Umibe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takeshi Umibe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takeshi Umibe more than expected).
Fields of papers citing papers by Takeshi Umibe
This network shows the impact of papers produced by Takeshi Umibe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takeshi Umibe. The network helps show where Takeshi Umibe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Takeshi Umibe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2024 | 6 | |
| 3 | 2023 | 12 | |
| 4 | 2019 | 13 | |
| 5 | 2018 | 44 | |
| 6 | 2017 | 15 | |
| 7 | 2016 | 9 | |
| 8 | 2016 | 3 | |
| 9 | [Case Report A case of TAFRO syndrome successfully treated with intravenous cyclophosphamide therapy]. | 2016 | 4 |
| 10 | 2014 | 81 | |
| 11 | 2014 | 2 | |
| 12 | Anti-tumor necrosis factor therapy in patients with difficult-to-treat lupus nephritis: a prospective series of nine patients. | 2009 | 41 |
| 13 | 2006 | 4 | |
| 14 | 2000 | 8 | |
| 15 | 1996 | 0 | |
| 16 | 1995 | 14 | |
| 17 | [Thrombotic thrombocytopenic purpura (TTP) observed in a patient with primary antiphospholipid antibody syndrome]. | 1994 | 3 |
About Takeshi Umibe
Takeshi Umibe is a scholar working on Rheumatology, Nephrology and Genetics, having authored 17 papers that have together received 262 indexed citations. Recurring topics across this work include Vasculitis and related conditions (4 papers), Renal Diseases and Glomerulopathies (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Asthma and respiratory diseases (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Eosinophilic Disorders and Syndromes (2 papers), Vascular Malformations and Hemangiomas (2 papers) and Viral Infections and Immunology Research (2 papers). The work is most often cited by research in Rheumatology (168 citations), Immunology (66 citations) and Genetics (32 citations). Takeshi Umibe has collaborated with scholars based in Japan and Austria. Frequent co-authors include Hiroshi Nakajima, Ryutaro Matsumura, Kei Ikeda, Shunsuke Furuta, Takao Sugiyama, Itsuo Iwamoto, Shin‐ichiro Kagami, Masaki Hiraguri, Makoto Sueishi and M. Yamagata. Their work appears in journals such as PLoS ONE, Journal of Allergy and Clinical Immunology and Annals of the Rheumatic Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.